CGTI request access

Cell & Gene Therapy Innovation · the Circle

The therapy
has moved.

What delivers. What sustains.
Who reaches the patient.

Hotel Palace Berlin · 10–11 February 2027

the Why

Four premises.
One room.

01

The science
is approved.

Cell and gene therapy has crossed from experimental to clinical. Multiple modalities are approved. The constraint now is not the biology — it is the system that delivers the biology to the patient.

02

The system
is not ready.

Manufacturing scalability, supply chain resilience, reimbursement architecture and regulatory coherence remain unsolved at the scale the field demands. The delay costs lives.

03

The decisions
are being made now.

Platform choices, CMC commitments, vector supply partnerships and market access strategy are being set by a small number of principals. Those decisions will define patient outcomes for a decade.

04

The format
is the work.

CGTI is closed. Invite-only. No audience, no broadcast, no performative Q&A. The conversation is structured around decisions, not presentations. The room is the mechanism.

The gap is not scientific.
It is systemic.

Approved therapies sit in manufacturing pipelines that cannot scale. Vector supply constraints delay trials. Reimbursement models do not reflect the value of curative interventions. These are decision problems, not science problems. CGTI is the room where those decisions are tested — by the principals who must make them.

The conversation at CGTI is structured around the decisions the field cannot defer. Not what could be done. What will be decided.

in the room.

the Room

Where the conversation
takes form.

The principals who shape cell and gene therapy at the level of science, operations and clinical delivery.

CGTI convenes CDOs, CMOs, heads of manufacturing, clinical operations leads and regulatory strategy principals. Not from every organisation — from the ones where the decisions are actually made.

The room

Closed. Invite-only. The chair is a practitioner, not a moderator. The structure is built for alignment, not performance.

View faculty

Faculty

The principals
in the room.

photo from the Circle forum, Cell and Gene Therapy Innovation 2027, faculty member

Faculty name
on confirmation

Role · Department

Organisation

photo from the Circle forum, Cell and Gene Therapy Innovation 2027, faculty member

Faculty name
on confirmation

Role · Department

Organisation

photo from the Circle forum, Cell and Gene Therapy Innovation 2027, faculty member

Faculty name
on confirmation

Role · Department

Organisation

Faculty grid populated on receipt of confirmed CSV (published records, deduplicated, rows of 3). Chair is never a card.

in the room.

photo from the Circle forum, Cell and Gene Therapy Innovation, Hotel Palace Berlin

Where it convenes.

The room, across
the Circle.

Berlin · Singapore · London

photo from the Circle forum, Cell and Gene Therapy Innovation

Berlin 2027

photo from the Circle forum, CGTI leadership forum

the Room

photo from the Circle forum, Cell and Gene Therapy Innovation 2027

the Conversation

photo from the Circle forum, CGTI 2027

in the room.

photo from the Circle forum, Cell and Gene Therapy Innovation

Hotel Palace Berlin

photo from the Circle forum, CGTI leadership

the Circle

The organisations
in the room.

Confirmed organisations across cell therapy, gene therapy, vector manufacturing, CDMOs, regulatory and reimbursement. The wall reflects the room.

Company wall populated on receipt of confirmed delegate list. Rows of 6, white 1:1 tiles, institutional register.

View full profile →